Kiniksa Pharmaceuticals International (KNSA) EPS (Basic) Growth (1y) (2018 - 2026)
Kiniksa Pharmaceuticals International (KNSA) EPS (Basic) Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.23 Bn | 43.26 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.82 Bn | 40.16 Bn | 2.15 Bn | -301.82% |
| 3 | Zoetis | 32.64 Bn | 30.96 Bn | 1.05 Bn | 1.21% |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | -17.09% |
| 5 | United Therapeutics | 22.38 Bn | 19.71 Bn | 683.80 Mn | 13.91% |
| 6 | Viatris | 18.88 Bn | 17.99 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 31.67% |
| 8 | Elanco Animal Health | 11.96 Bn | 11.43 Bn | 798.00 Mn | 388.06% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Kiniksa Pharmaceuticals International | 6.14 Bn | 5.61 Bn | 220.03 Mn | 35.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 35.01% |
| Mar 31, 2026 | 151.19% |
| Dec 31, 2025 | 253.78% |
| Sep 30, 2025 | 239.43% |
| Jun 30, 2025 | 541.17% |
| Mar 31, 2025 | 146.89% |
| Dec 31, 2024 | 82.30% |
| Sep 30, 2024 | 10.35% |
| Jun 30, 2024 | -125.70% |
| Mar 31, 2024 | -42.49% |
| Dec 31, 2023 | -155.09% |
| Sep 30, 2023 | -106.12% |
| Jun 30, 2023 | 174.26% |
| Mar 31, 2023 | 51.76% |
| Dec 31, 2022 | 298.51% |
| Sep 30, 2022 | 825.41% |
| Jun 30, 2022 | 52.55% |
| Mar 31, 2022 | 49.69% |
| Dec 31, 2021 | 33.09% |
| Sep 30, 2021 | 33.07% |